US Patent 10307371 Rapamycin for the treatment of lymphangioleiomyomatosis
Patent 10307371 was granted and assigned to AI Therapeutics on June, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 3, 2017
0
Date of Patent
June 4, 2019
0
Patent Applicant
Patent Application Number
15803005
0
Patent Inventor Names
Henri Lichenstein
0
Lawrence S. Melvin, Jr.
0
Thomas Armer
0
Jonathan M. Rothberg
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10307371 Rapamycin for the treatment of lymphangioleiomyomatosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
